Alzheimer's Disease Genetics Study: Alzheimer's disease genetics initiative: the multiplex family study

Alzheimer's Oral Medication Study: A phase II study of an oral medication developed to block the receptor for advanced glycation end products which damage nerve cells in the brain

Alzheimer's Vaccine Study: A first-in-human, phase I study of the safety of an intramuscular vaccine against beta-amyloid in persons with mild-to-moderate Alzheimer's disease

Blood Markers, Inflammation and Oxidative Stress Study: A six-month, double-blind, placebo-controlled, single-site study of Cerefolin NAC on blood homocysteine, oxidative stress, and beta-amyloid biomarkers that may potentiate inflammation and neuronal damage

Home-Based Assessment Methods for Alzheimer's Disease: Multicenter trial to evaluate home-based assessment methods for Alzheimer's disease prevention research in people over 75 years old (ADC-030-HBA)

Mild Alzheimer's Study: Daytime sleepiness and parkinsonism in patients with mild Alzheimer's disease

Mild to Severe Alzheimer's While Residing in an Assisted Living Facility: A 12-week, open-label study of the safety and efficacy of donepezil hydrochloride in subjects with mild to severe Alzheimer's disease residing in an assisted living facility

Moderate-to-Severe Alzheimer's Disease Study: A study of a sustained-release, higher dose formulation of donepezil for the treatment of moderate-to-severe Alzheimer's disease

Telephone Resources and Assistance for Caregivers Study: Telephone Resources and Assistance for Caregivers (TRAC)